Stock listing

0L35 Stock Price, News, Filings & Events — Sarepta Therapeutics, Inc.

Selected listing: 0L35 · LSE · USD · GB

This page tracks Sarepta Therapeutics, Inc.'s 0L35:LSE listing on LSE in USD for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 0L35:LSE. 0L35:LSE is the stock-level entry point for investors researching Sarepta Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Sarepta Therapeutics, Inc. (SRPT) is a public company based in the United States, focusing on developing innovative therapies for rare diseases, particularly genetic disorders. With a market capitalization of approximately $1.82 billion, Sarepta is recognized for its commitment to advancing treatment options for patients with serious unmet medical needs. The company is actively engaged in research and development to bring new...

0L35:LSEUSDGBUpdated July 24, 2026
Sarepta Therapeutics, Inc. logo
Ticker
0L35:LSE
Asset type
Stock
Market cap
$1.66B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
LSE
Currency
USD

Sarepta Therapeutics, Inc. 0L35:LSE stock context

This page tracks Sarepta Therapeutics, Inc.'s 0L35:LSE listing on LSE in USD for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 0L35:LSE. 0L35:LSE is the stock-level entry point for investors researching Sarepta Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Sarepta Therapeutics, Inc. (SRPT) is a public company based in the United States, focusing on developing innovative therapies for rare diseases, particularly genetic disorders. With a market capitalization of approximately $1.82 billion, Sarepta is recognized for its commitment to advancing treatment options for patients with serious unmet medical needs. The company is actively engaged in research and development to bring new...

Research Sarepta Therapeutics, Inc.

Alternate listings